Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Regeneron: Sanofi Plans to Increase Stake to Over $500 Million of Stock

02/11/2013 | 10:44am US/Eastern
   By Melodie Warner 
 

Regeneron Pharmaceuticals Inc. (>> Regeneron Pharmaceuticals Inc) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and push its ownership of voting securities to more than $500 million.

Sanofi currently holds about 17% of Regeneron's shares outstanding, according to FactSet Research.

Regeneron said a December 2007 investor agreement bonds the French drug maker to certain standstill provisions, including an agreement not to acquire more than 30% of Regeneron's Class A stock and common stock outstanding.

Regeneron said these standstill provisions are in effect until the fifth anniversary of the expiration of a license and collaboration agreement between the companies.

Sanofi and Regeneron have worked together on experimental cancer drug Zaltrap, among other things.

Shares of Regeneron rose 5.6% to $175.13 in recent trading and have climbed 24% in the past three months.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Regeneron Pharmaceuticals Inc
React to this article
Latest news on REGENERON PHARMACEUTICALS
03:22p REGENERON PHARMACEUTICALS : Robbins Arroyo LLP : Is Investigating Regeneron Phar..
03:03p REGENERON PHARMACEUTICALS : EYLEA® aflibercept Injection Receives Approval in Ja..
06/29 REGENERON PHARMACEUTICALS : Rapid Response Platform for Emerging Infectious Dise..
06/26 New Sanofi CEO to unveil five-year plan in November - unions
06/26 REGENERON PHARMACEUTICALS : EYLEA® (aflibercept) Injection Receives Approval in ..
06/25 REGENERON PHARMACEUTICALS : Announces 2015 Winners of the Prize for Creative Inn..
06/23 REGENERON PHARMACEUTICALS : Federal Contracts Awarded by Federal Agencies in Ill..
06/23 REGENERON PHARMACEUTICALS : $470 Million Federal Contract Awarded to Regeneron P..
06/17 REGENERON PHARMACEUTICALS : Change in Directors or Principal Officers, Submissio..
06/17 REGENERON PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of Regene..
Advertisement
Chart
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Income Statement Evolution
More Financials